“Immune Checkpoint Marker of Programmed Death Ligand-1 (PD-L1) Expression in Surgical Lung Cancer Specimens”, J Respirol Indones, vol. 42, no. 2, pp. 136–140, Apr. 2022, doi: 10.36497/jri.v42i2.286.